Spain · AEMPS CIMA

vacuna anti COVID-19 (Novavax) proteína recombinante de la espícula de SARS-COV-2 (OMICRON JN.1)

Source ingredient · 2 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.